TPNI (Non-Invasive Prenatal Test)

• Peace of mind from the beginning of pregnancy: available from week 9.
•Non-invasive: performed with a simple maternal blood sample, with no risk to you or your baby.
•Technically superior: detects conditions that other tests do not identify, such as molar pregnancy, triploidy or vanishing twin syndrome.
•Unique genetic profiling: the only test that distinguishes between maternal and fetal DNA, reducing false-positive and false-negative results.
•Twin pregnancies: evaluates zygosity, the individual fetal sex and the fetal fraction of each twin.
•High accuracy: more than 99% reliability in detecting Down syndrome and other common trisomies (18 and 13).
•Versatility: suitable for singleton, egg donation and twin pregnancies.
•The most comprehensive NIPT range in Spain: if you require a broader study, Echevarne is the only laboratory on the market offering the Monogenic NIPT, capable of detecting 202 dominant monogenic diseases involving 155 genes.

The purchase of this test is a voucher for taking the test at a Laboratorio Echevarne branch.

Fasting is not required.

It is recommended to eat something 30 minutes before the analysis.

Extractions available Monday to Friday (except on the eve of public holiday Fridays).

A medical request is mandatory to perform this test.

Before visiting the laboratory, you must first see a doctor so they can provide you with the prescription and complete the information on this document.

CLICK HERE.

Your results, clear and easy to access: within 8 working days* you will receive a notification by email and SMS. Once notified, you will be able to access and download your report from our online Patient Portal.
In some cases, the turnaround time may be extended due to technical requirements.

Interpretation of results:
•Low risk: confirms with 99% certainty that the fetus does not have the analysed syndromes, although it does not completely rule out other abnormalities.
•High risk: it is essential to consult your gynaecologist. As with any screening test, there is a minimal possibility of a false-positive result, so confirmation requires a definitive diagnostic test, such as amniocentesis.

The NIPT (Non-Invasive Prenatal Test) is a maternal blood test that analyses fetal DNA to detect the main fetal chromosomal abnormalities: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome), without posing any risk to either the mother or the baby.

You can have the NIPT from week 9 of pregnancy, making it one of the earliest prenatal screening tests available.

No. The NIPT is a non-invasive test performed using a simple maternal blood sample, avoiding the risks associated with invasive procedures such as amniocentesis or chorionic villus sampling.

The NIPT offers an accuracy rate of over 99% for detecting Down syndrome and other common trisomies (18 and 13). By distinguishing maternal DNA from fetal DNA, it significantly reduces the risk of false-positive and false-negative results compared with other screening methods, such as the combined first-trimester screening.

Yes. The standard NIPT is suitable for singleton pregnancies (natural or through egg donation) and natural twin pregnancies. If your pregnancy is a twin pregnancy through egg donation or you require a more comprehensive assessment, please consult our NIPT range for Special Cases.

A high-risk result is not a definitive diagnosis; it indicates that the test has identified a high probability. It is essential that you consult your gynaecologist, who may confirm the result with a definitive diagnostic procedure such as amniocentesis.